| WM + cortical MS lesion versus experimental demyelination |
| stearate biosynthesis |
0.0004 |
0.006 |
HumanCyc |
ACSL1; ELOVL1 |
| cholesterol biosynthesis |
0.0006 |
0.006 |
Wikipathways |
MVD; DHCR7 |
| PPAR signaling pathway |
0.0006 |
0.006 |
KEGG |
LPL; ACSL1; ANGPTL4 |
| synthesis of very long-chain fatty acyl-CoAs |
0.0008 |
0.006 |
Reactome |
ACSL1; ELOVL1 |
| omega-3 fatty acid metabolism |
0.0009 |
0.006 |
EHMN |
ACSL1; ELOVL1 |
| activation of gene expression by SREBP (SREBF) |
0.001 |
0.006 |
Wikipathways |
MVD; DHCR7 |
| metabolism of lipids and lipoproteins |
0.001 |
0.006 |
Reactome |
SYNJ2; ACSL1; DHCR7; LPL; MVD; ELOVL1 |
| fatty Acyl-CoA biosynthesis |
0.001 |
0.006 |
Reactome |
ACSL1; ELOVL1 |
| cholesterol biosynthesis |
0.002 |
0.0065 |
Reactome |
MVD; DHCR7 |
| activation of gene expression by SREBF (SREBP) |
0.002 |
0.0065 |
Reactome |
MVD; DHCR7 |
| superpathway of cholesterol biosynthesis |
0.002 |
0.007 |
HumanCyc |
MVD; DHCR7 |
| regulation of cholesterol biosynthesis by SREBP (SREBF) |
0.002 |
0.007 |
Reactome |
MVD; DHCR7 |
| amb2 Integrin signaling |
0.0025 |
0.007 |
PID |
RAP1A; JAM3 |
| omega-6 fatty acid metabolism |
0.003 |
0.009 |
EHMN |
ACSL1; ELOVL1 |
| fatty acid beta oxidation |
0.005 |
0.01 |
Wikipathways |
ACSL1; LPL |
| triglyceride biosynthesis |
0.006 |
0.01 |
Reactome |
ACSL1; ELOVL1 |
| class I PI3K signaling events |
0.009 |
0.02 |
PID |
CYTH1; RAP1A |
| integrated breast cancer pathway |
0.009 |
0.02 |
Wikipathways |
XRCC3; RAP1A |
| WM + cortical MS lesion versus experimental remyelination |
| glial cell differentiation |
0.0002 |
0.006 |
Wikipathways |
MBP; MAG |
| osteoclast differentiation |
0.0003 |
0.006 |
KEGG |
TYROBP; TNFRSF1A; CYBA; TREM2 |
| other semaphorin interactions |
0.001 |
0.02 |
Reactome |
TYROBP; TREM2 |
| RANKL |
0.002 |
0.02 |
NetPath |
TYROBP; TREM2 |
| basigin interactions |
0.002 |
0.02 |
Reactome |
SLC7A7; MAG |
| spinal cord injury |
0.003 |
0.02 |
Wikipathways |
MBP; AIF1; MAG |
| hiv-1 nef: negative effector of fas and tnf |
0.008 |
0.04 |
BioCarta |
GSN; TNFRSF1A |
| cardiac hypertrophic response |
0.0085 |
0.04 |
Wikipathways |
FGFR2; TNFRSF1A |
| DAP12 signaling |
0.009 |
0.04 |
Reactome |
TYROBP; FGFR2; TREM2 |
| caspase cascade in apoptosis |
0.009 |
0.04 |
PID |
GSN; TNFRSF1A |
